BIMM

BIMM integrates single-cell RNA sequencing (scRNA-seq) and proteomics to infer signaling pathway perturbations and build multiscale models for analyzing Dexamethasone (DEX) treatment responses in lung adenocarcinoma-derived A549 cells.


Key Features:

  • Integration of Multi-Omics Data: Combines scRNA-seq and proteomic datasets to identify differentially expressed genes (DEGs) in A549 cells following Dexamethasone (DEX) treatment.
  • Identification of Hub Genes: Constructs regulatory networks from DEGs to identify hub genes such as TGFβ, MYC, and SMAD3 that change with DEX treatment.
  • Pathway Analysis and Enrichment: Performs gene set enrichment analysis to determine enriched signaling pathways, with TGFβ signaling identified as a top enriched term.
  • Network Modeling and Simulation: Builds multiscale models that incorporate TGFβ-induced and ERBB-amplified signaling pathways to simulate dynamic effects of DEX therapy on tumor regulation.
  • Predictive Capabilities: Generates dose- and time-dependent predictive models for DEX treatment and validates predictions against protein-level data for SMAD2, FOXO3, TGFβ1, and TGFβR1 over a time course.
  • Cross-Disciplinary Application: Applies the multi-omics integration and multiscale modeling framework to study tumorigenesis and oncotherapy across different cancer contexts.

Scientific Applications:

  • Drug Response Analysis: Dissects molecular mechanisms of DEX response in lung cancer by linking DEGs, hub genes, and pathway perturbations.
  • Therapeutic Target Identification: Prioritizes hub genes and enriched pathways such as TGFβ signaling as candidate targets for therapeutic intervention.
  • Modeling Tumor Dynamics: Uses multiscale simulations to explore tumor behavior under varying DEX doses and time courses.

Methodology:

Identification of DEGs in treated cells; construction of regulatory networks to pinpoint hub genes; gene set enrichment/pathway analysis; integration of results into a multiscale model to simulate tumor dynamics with validation against biological data and literature curation.

Topics

Details

License:
Not licensed
Tool Type:
command-line tool
Operating Systems:
Mac, Windows
Programming Languages:
MATLAB, R
Added:
10/6/2022
Last Updated:
11/24/2024

Operations

Publications

Chen M, Xu C, Xu Z, He W, Zhang H, Su J, Song Q. Uncovering the dynamic effects of DEX treatment on lung cancer by integrating bioinformatic inference and multiscale modeling of scRNA-seq and proteomics data. Computers in Biology and Medicine. 2022;149:105999. doi:10.1016/j.compbiomed.2022.105999. PMID:35998480. PMCID:PMC9717711.